Top Institutions in Endocrinology
The ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.
-
#1
University of Michigan – Michigan Medicine, W.K. Kellogg Eye Center
Ann Arbor, Michigan
Michigan led the bench-to-bedside work identifying IGF-1R in TED pathogenesis and co-led the pivotal Phase 2 and Phase 3 studies that established teprotumumab’s efficacy.
Key Differentiators
- Endocrinology
- Ophthalmology
-
#2
Cedars-Sinai Medical Center
Los Angeles, California
Cedars-Sinai’s Raymond S. Douglas was lead author of the NEJM Phase 3 OPTIC trial and continues to drive prospective studies in TED.
Key Differentiators
- Endocrinology
- Ophthalmology
-
#3
Dana-Farber Cancer Institute
Boston, Massachusetts
Dana-Farber's involvement in the Phase 3 study highlights its commitment to advancing treatment for TED.
Key Differentiators
- Oncology
- Endocrinology
-
#4
Byers Eye Institute, Stanford University School of Medicine
Stanford, California
The institute is recognized for its contributions to ophthalmology and its involvement in TED research.
Key Differentiators
- Ophthalmology
- Endocrinology
-
#5
Vall d’Hebron Institute of Oncology
Barcelona, Spain
The institute is noted for its research in oncology and its contributions to TED therapy.
Key Differentiators
- Oncology
- Endocrinology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
